NWJClass II
Suture, Recombinant Technology
21 CFR 878.4494 / General, Plastic Surgery
NWJ is the FDA product code for Suture, Recombinant Technology, a class II device type, regulated under 21 CFR 878.4494. FDA's definition for this code reads: "Intended for use in soft tissue approximation. Indicated for use in general soft tissue approximation and/or ligation". As of , FDA records hold 9 510(k) clearances under this code, the most recent dated , and one recall.
Classification record
- Product code
- NWJ
- Device name
- Suture, Recombinant Technology
- FDA definition
- Intended for use in soft tissue approximation. Indicated for use in general soft tissue approximation and/or ligation.
- Regulation
- 21 CFR 878.4494
- Device class
- Class II
- Review panel
- General, Plastic Surgery
- Submission type
- 510(k)
- Implant
- Yes
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 9
- Ingested recalls
- 1
Clearances, product code NWJ
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2007 | 2 |
| 2008 | 2 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2021 | 1 |
Applicants with the most clearances
Product code NWJ| Applicant | Clearances |
|---|---|
| Tepha, Inc. | 4 |
| TORNIER Inc. | 2 |
| Aesculap Inc | 1 |
| Entrigue Surgical, Inc. | 1 |
| Tepha, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
